Predictors of Discordance Between Dry Eye Symptoms and Signs: Insights From the Sjögren's International Collaborative Clinical Alliance
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.12.3 ↗At a glance
Multizentrische Studie in Investigative Ophthalmology & Visual Science, 2024. Written by Fanxiu Xiong and 3 co-authors. Institution: Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States. Major MEDLINE topics: Dry Eye Syndromes. Cited 13 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS, NIDCR NIH HHS.
Abstract (original language)
Purpose
The diagnosis and management of dry eye disease (DED) could be complicated by the discordance between DED-related symptoms and signs. We performed a cross-sectional study to investigate the factors of and develop predictive models for the discrepancy in DED symptomatology.
Methods
We used data from 3455 participants, 21 to 89 years old, from the Sjögren's International Collaborative Clinical Alliance study. We performed a multivariable stepwise linear regression model with backward elimination and Bayesian information criteria to select predictors for the discordance in DES symptomatology, which was defined as the difference between the rank score of Ocular Surface Disease Index 6 (OSDI-6) and the rank score of ocular staining score (OSS).
Results
Ten predictors, such as "vitality," "immunomodulating drugs," sensory symptoms," and "ethnicity," remained in the final models, achieving an adjusted R2 (aR2) of 0.35 (95% confidence interval [CI], 0.32-0.39). Specifically, medication use explained 19% (95% CI, 0.17-0.22) of the variance in the outcome, followed by medical history (aR2 = 0.18; 95% CI, 0.15-0.21). Health-related quality of life contributed 16% to the variance in the outcome (95% CI, 0.13-0.19), and, last, demographics contributed 11% (95% CI, 0.09-0.13).
Conclusions
Our results suggest that individuals of Asian descent and those using immunomodulating medications often present with severe ocular signs that necessitate regular ophthalmological evaluations, even in the absence of proportionate ocular symptoms. Additionally, ocular symptoms, when accompanied by abnormal sensations in other parts of the body, could indicate systemic conditions that require further investigation and medical care.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States.
- Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States.
Funding
- NEI NIH HHS
- NIDCR NIH HHS
Cite
APA
Xiong, F., Arnold, B. F., Lietman, T. M., & Gonzales, J. A. (2024). Predictors of Discordance Between Dry Eye Symptoms and Signs: Insights From the Sjögren's International Collaborative Clinical Alliance. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.12.3
Vancouver
Xiong F, Arnold BF, Lietman TM, Gonzales JA. Predictors of Discordance Between Dry Eye Symptoms and Signs: Insights From the Sjögren's International Collaborative Clinical Alliance. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.12.3
BibTeX
@article{Xiong2024,
author = {Xiong, Fanxiu and Arnold, Benjamin F and Lietman, Thomas M and Gonzales, John A},
title = {Predictors of Discordance Between Dry Eye Symptoms and Signs: Insights From the Sjögren's International Collaborative Clinical Alliance},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.12.3}
}
EUVIMED